MENU
HEPA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Hepion Pharmaceuticals (HEPA) Earnings Date & Reports

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases... Show more

A.I. Advisor
published Earnings

HEPA is expected to report earnings to rise 61.11% to -290 cents per share on May 16

Hepion Pharmaceuticals HEPA Stock Earnings Reports
Q1'23
Est.
$-2.90
Q4'22
Missed
by $1.68
Q3'22
Beat
by $0.06
Q2'22
Missed
by $4.94
Q1'22
Est.
$-0.09
The last earnings report on March 01 showed earnings per share of -179 cents, missing the estimate of -11 cents. With 1.14M shares outstanding, the current market capitalization sits at 442.80K.
View a ticker or compare two or three
HEPA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a pharmaceutical company, which engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
399 Thornall Street
Phone
+1 732 902-4000
Employees
25
Web
https://www.hepionpharma.com